Enhanced expression of the urokinase type plasminogen activator gene and reduced colony formation in soft agar by ectopic expression of PU.1 in HT1080 human fibrosarcoma cells

British Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 718-723

  Kondoh, N ^a,b   Yamada, T ^a   Kihara Negishi, F ^a   Yamamoto, M ^b   Oikawa, T ^a  

^a SASAKI INSTITUTE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Cell growth; Cell migration; PU.1 gene; Urokinase type plasminogen activator

Indexed keywords

AGAR; DEXAMETHASONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU1; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CLONING VECTOR; COLONY FORMATION; CONTROLLED STUDY; DNA TRANSFECTION; FIBROSARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE N RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031659052     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.567     Document Type: Article

References (35)

1. Altus MS and Nagamine Y (1991) Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. J Biol Chem 266: 21190-21196
2. Altus MS, Pearson D, Horiuchi A and Nagamine Y (1987) Inhibition of protein synthesis in LLC-PK1 cells increased calcitonin-induced plasminogen-activator gene transcription and mRNA stability. Biochem J 242: 387-392
3. Chambers SK, Wang Y, Gerts RE and Kacinski BM (1995) Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res 55: 1578-1585
4. Darby TG, Meißner JD, Rühlmann A, Mueller WH and Scheib RJ (1997) Functional interference between retinoic acid or steroid hormone receptors and oncoprotein Fli-1. Oncogene 15: 3067-3082
5. Feinberg AP and Vogelstein BA (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13
6. Galang CK, Der CJ and Hauser CA (1994) Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene 9: 2913-2921
7. Gauthier J-M, Bourachot B, Daucaus V, Yaniv M and Moreau-Gachelin F (1993) Functional interaction between Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J 12: 5089-5096
8. Gunning P, Ponte P, Kedes Lhickei PJ and Scoultchi AI (1984) A sarcomeric actin associates with a nonmuscle cytoskeleton. Cell 36: 709-715
9. Hall A, Marshall CJ, Spurr NK and Weiss RA (1983) Identification of transforming gene in two human sarcoma cells as a new member of ras gene family located on chromosome 1. Nature 303: 396-400
10. Henderson BR and Kefford RF (1991) Conservation and potential role of RNA-instability motifs in urokinase gene 3′-untranslated sequences. J Natl Cancer Inst 83: 1103-1104
11. Henderson BR, Tansey WP, Phillip SM, Ramshaw IA and Kefford RF (1992) Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res 52: 2489-2496
12. Hung H-JS, Yee J, Shew J, Chen P, Bookstein R, Friedmann T, Lee EY-HP and Lee W (1988) Suppression of the neoplastic phenotypes by replacement of the RB gene in human cancer cells. Science 242: 1563-1566
13. Kirchheimer JC and Remold HG (1989) Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol 143: 2634-2639
14. Klemsz MJ, Mckercher SR, Celada A, Van Beveran C and Maki RA (1990) The macrophage and B-cell-specific transcription factor PU.1 is restricted to the ets oncogene. Cell 61: 113-124
15. Kondoh N, Oikawa T, Satoh C and Kuzumaki N (1991) Effects of sodium butyrate on the rearranged c-myc expression in mouse plasmacytoma cells. Exp Cell Res 196: 146-149
16. Kondoh N, Schweinfest CW, Henderson KW and Papas TS (1992) Differential expression of S29 ribosomal protein, laminin-binding protein and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 52: 791-796
17. Langer SJ, Bortner DM, Roussel MF, Sherr CJ and Ostrowski MC (1992) Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc over-expression. Mol Cell Biol 12: 5355-5362
18. Littlefield BA, Johnson LJ, Manzer DS and Roche PC (1985) Glucocorticoid inhibition of urokinase-like plasminogen activators in cultured human lymphoblasts. Endocrinology 117: 1100-1109
19. Medcalf RL, Richard RI, Crawford RJ and Hamilton JA (1986) Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. EMBO J 5: 2217-2222
20. Moreau-Gachelin F (1994) Spi-1/PU.1: an oncogene of Ets family. Biochim Biophys Acta 1198: 149-163
21. Moreau-Gachelin F, Tavitian A and Tambourin P (1988). Spi-1 is a putative oncogene in virally induced murine erythroleukemias. Nature 331: 277-280
22. Moreau-Gachelin F, Wendling F, Molina T, Denis N, Titeux M, Grimber G, Briand P, Vainchenker W and Tavitian A (1996) Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol 16: 2453-2463
23. Nerlov C, Rorth P, Blasi F and Johnsen M (1991) Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6: 1583-1592
24. Paterson H, Reeves B, Brown R, Hall A, Furth M, Bos J, Jones P and Marshall C (1987) Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell 51: 803-812
25. Paul R, Schuetze S, Kozak SL, Kozak CA and Kabat D (1991) The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor PU.1. J Virol 65: 464-467
26. Schuetze S, Stenberg P and Kabat D (1993) The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol Cell Biol 13: 5670-5678
27. Simon MC, Olson M, Scott E, Hack A, Su G and Singh H (1996) Terminal myeloid gene expression and differentiation requires the transcription factor PU.1. Curr Top Micro Immunol 211: 113-119
28. Stacey KJ, Fowles LF, Colman MS, Ostrowski MC and Hume DA (1995) Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol Cell Biol 15: 3430-3441
29. Suzuki H, Romano-Spica V, Papas TS and Bhat NK (1996) ETS1 suppresses tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA 92: 4442-4446
30. Taparowsky K, Shimizu K, Goldfarb M and Wigler M (1983) Structure and activation of the human N-ras gene. Cell 34: 581-586
31. + RNA. Proc Natl Acad Sci USA 81: 4727-4731
32. Wasylyk B, Wasylyk C, Flores P, Begue A, Leprine D and Stehelin D (1990) The ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 346: 191-193
33. Wasylyk C, Maria S-M, Sobieszczuk P and Wasylyk B (1994) Reversion of Ras transformed cells by Ets transdominant mutants. Oncogene 9: 3665-3673
34. Yamada T, Kondoh N, Matsumoto M, Yoshida M, Maekawa A and Oikawa T (1997) Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood 89: 1383-1393
35. 2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-dependent mechanism. J Biol Chem 265: 21194-21201